These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6690072)

  • 1. Phase-I trial of UltrapureTM human leukocyte interferon in human malignancy.
    Budd GT; Bukowski RM; Miketo L; Yen-Lieberman B; Proffitt MR
    Cancer Chemother Pharmacol; 1984; 12(1):39-42. PubMed ID: 6690072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I-II trial of intraperitoneal cisplatin and alpha-interferon in patients with persistent epithelial ovarian cancer.
    Berek JS; Welander C; Schink JC; Grossberg H; Montz FJ; Zigelboim J
    Gynecol Oncol; 1991 Mar; 40(3):237-43. PubMed ID: 2013446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I study of human leukocyte interferon in patients with advanced cancer.
    Horning SJ; Levine JF; Meyer M; Merigan TC; Rosenberg SA
    J Biol Response Mod; 1983; 2(1):47-56. PubMed ID: 6196450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia.
    Foon KA; Bottino GC; Abrams PG; Fer MF; Longo DL; Schoenberger CS; Oldham RK
    Am J Med; 1985 Feb; 78(2):216-20. PubMed ID: 3970047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I trial of recombinant leukocyte alpha 2 interferon in patients with advanced malignancy.
    Muss HB; Richards F; Homesley HD; Spurr CL; Rudnick SA; Stuart JJ; Plunkett S; Welander C; Caponera M; White DR
    Am J Clin Oncol; 1985 Apr; 8(2):97-107. PubMed ID: 3834792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.
    Figlin RA; deKernion JB; Maldazys J; Sarna G
    Cancer Treat Rep; 1985 Mar; 69(3):263-7. PubMed ID: 3978656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I evaluation of a synthetic mutant of beta-interferon.
    Hawkins M; Horning S; Konrad M; Anderson S; Sielaff K; Rosno S; Schiesel J; Davis T; DeMets D; Merigan T
    Cancer Res; 1985 Nov; 45(11 Pt 2):5914-20. PubMed ID: 4053062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I clinical trial of recombinant DNA gamma interferon.
    Brown TD; Koeller J; Beougher K; Golando J; Bonnem EM; Spiegel RJ; Von Hoff DD
    J Clin Oncol; 1987 May; 5(5):790-8. PubMed ID: 3106584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
    Sarna G; Figlin R; McCarthy S
    J Biol Response Mod; 1983; 2(2):187-95. PubMed ID: 6644335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II study on escalating interferon doses in advanced ovarian carcinoma.
    Einhorn N; Ling P; Einhorn S; Strander H
    Am J Clin Oncol; 1988 Feb; 11(1):3-6. PubMed ID: 3277373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of recombinant beta ser 17 interferon in the treatment of cancer.
    Sarna G; Pertcheck M; Figlin R; Ardalan B
    Cancer Treat Rep; 1986 Dec; 70(12):1365-72. PubMed ID: 3791249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended phase I study of human beta-interferon in human cancer.
    Abdi EA; Kamitomo VJ; McPherson TA; Konrad MW; Inoue M; Tan YH
    Clin Invest Med; 1986; 9(1):33-40. PubMed ID: 3955919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of weekly high-dose human lymphoblastoid interferon.
    Connors JM; Silver HK
    Cancer Treat Rep; 1984 Sep; 68(9):1093-6. PubMed ID: 6478449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical phase II trial of recombinant DNA interferon (interferon alpha 2b) in patients with metastatic malignant melanoma.
    Dorval T; Palangie T; Jouve M; Garcia-Giralt E; Israel L; Falcoff E; Schwab D; Pouillart P
    Cancer; 1986 Jul; 58(2):215-8. PubMed ID: 3719515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of recombinant human interferon beta in patients with advanced cancer.
    Hu E; Horning SJ
    J Biol Response Mod; 1987 Apr; 6(2):121-9. PubMed ID: 3585409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II trial of human recombinant beta-interferon serine in patients with renal cell carcinoma.
    Rinehart J; Malspeis L; Young D; Neidhart J
    Cancer Res; 1986 Oct; 46(10):5364-7. PubMed ID: 3756886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I trial of natural human interferon beta in metastatic malignancy.
    Bukowski RM; Sergi JS; Sharfman WJ; Budd GT; Murthy S; Barna B; Medendorp SV; Yen-Lieberman B; Gibson V; Bauer L
    Cancer Res; 1991 Feb; 51(3):836-40. PubMed ID: 1988123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parameters of interferon action: II. Immunological effects of recombinant leukocyte interferon (IFN-alpha 2) in phase I-II trials.
    Ernstoff MS; Fusi S; Kirkwood JM
    J Biol Response Mod; 1983; 2(6):540-7. PubMed ID: 6607324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase II trial of high-dose intravenous interferon alpha-2 in advanced colorectal cancer.
    Silgals RM; Ahlgren JD; Neefe JR; Rothman J; Rudnick S; Galicky FP; Schein PS
    Cancer; 1984 Nov; 54(10):2257-61. PubMed ID: 6488145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.